Panacea Biotec share price locked at 5 percent upper circuit on December 26 following the company received Letter Of Award (LoA) from United Nations International Children's Emergency Fund (UNICEF) for supply of 115 million doses of its bivalent oral polio vaccine (bOPV).
At 09:20am, Panacea Biotec was quoting at Rs 456.25, up Rs 21.70, or 4.99 percent, on the BSE.
There were pending buy orders of 16,195 shares, with no sellers available.
The contract is worth ~ USD 14.95 million (~ Rs127 crore) and to be executed calendar year 2025.
The LoA is for supply of bOPV to UNICEF for its requirements in countries in Africa / Asia region as per the orders as may be received from time to time.
Catch all the market action on our live blog
The company had reported 158 percent jump in its Q2 net profit at Rs 4.80 crore.
The share price jumped 225 percent in last six months.
The share touched a 52-week high of Rs 489.00 and a 52-week low of Rs 112.70 on 12 December, 2024 and 04 June, 2024, respectively.
Currently, the stock is trading 6.7 percent below its 52-week high and 304.84 percent above its 52-week low.
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
